Medline Inc. (NASDAQ: MDLN) announced that certain selling stockholders have commenced an underwritten public offering of 60 million shares of the company's Class A common stock. The selling stockholders are affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority.

The selling stockholders have also granted underwriters a 30-day option to purchase up to an additional 9 million shares of Medline's Class A common stock. Medline will not sell any shares in the offering and will not receive proceeds from the sale.

Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities and J.P. Morgan are serving as global coordinators and joint bookrunning managers for the offering. Blackstone Capital Markets is acting as co-manager.

The offering will be conducted through a registration statement filed with the Securities and Exchange Commission, though the registration statement has not yet become effective. The securities cannot be sold until the registration statement becomes effective.

Medline describes itself as a provider of medical-surgical products and supply chain solutions serving healthcare facilities. The Northfield, Illinois-based company employs more than 45,000 people worldwide and operates in more than 100 countries.